Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06272734 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reprieve System Pilot Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v4
  2. Primary completion date: Jun 30, 2025 to Dec 31, 2025v3
  3. Enrollment target: 20 to 50 Primary completion date: Dec 31, 2024 to Jun 30, 2025 · Completion date: Jan 31, 2025 to Dec 31, 2025 · Eligibility criteria expanded, about 9 wordsv2 Show 3 more changesShow less
    • Primary completion date: Dec 31, 2024 to Jun 30, 2025
    • Completion date: Jan 31, 2025 to Dec 31, 2025
    • Eligibility criteria expanded, about 9 words

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to evaluate the use of the Reprieve System to decongest subjects with acute decompensated heart failure.
Trial Details
NCT Number NCT06272734
Lead Sponsor Reprieve Cardiovascular, Inc
Conditions Acute Decompensated Heart Failure
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov